"Designing Growth Strategies is in our DNA"

U.S. Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Albumin, Immunoglobulin [Intravenous Immunoglobulin {IVIG}, Subcutaneous Immunoglobulin {SCIG}], Coagulation Factors [Factor IX, Factor VIII, Prothrombin Complex Concentrates, Fibrinogen Concentrates, and Others], Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108476

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Plasma Collection Centers in the U.S., 2022
    2. Cost Breakdown of Plasma Fractionation in the U.S., 2022
    3. Key Industry Developments: Partnerships, Mergers & Acquisitions, etc
    4. Overview of Regulatory Scenario
    5. Prevalence of Chronic Diseases (Key Indications), 2022
    6. Overview of Plasma Collection Technologies
    7. Impact of COVID-19 on the Market
  5. U.S. Plasma Fractionation Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin (IVIG)
        2. Subcutaneous Immunoglobulin (SCIG)
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen concentrates
        5. Others
      4. Protease Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Pulmonology
      5. Others
    3. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others (Academic Institutes, etc.)
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Grifols, S.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Kedrion S.p.A
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Octapharma AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Bio Products Laboratory Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. LFB
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Plasma Collection Centers in the U.S., 2022
    2. Cost Breakdown of Plasma Fractionation in the U.S., 2022
    3. Key Industry Developments: Partnerships, Mergers & Acquisitions, etc
    4. Overview of Regulatory Scenario
    5. Prevalence of Chronic Diseases (Key Indications), 2022
    6. Overview of Plasma Collection Technologies
    7. Impact of COVID-19 on the Market
  5. U.S. Plasma Fractionation Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin (IVIG)
        2. Subcutaneous Immunoglobulin (SCIG)
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen concentrates
        5. Others
      4. Protease Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology & Neurology
      2. Hematology
      3. Critical Care
      4. Pulmonology
      5. Others
    3. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Clinical Research Laboratories
      3. Others (Academic Institutes, etc.)
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Grifols, S.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Kedrion S.p.A
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Octapharma AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Bio Products Laboratory Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. LFB
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Other Prominent Players
Read Less

Figure 1:  U.S. Plasma Fractionation Market Revenue Breakdown (USD billion, %), By Product, 2022 & 2030

Figure 2:  U.S. Plasma Fractionation Market Value Share (%), by Product, 2022 & 2030

Figure 3:  U.S. Plasma Fractionation Market Value Share (%), by Application, 2022 & 2030

Figure 4:  U.S. Plasma Fractionation Market Value Share (%), by End User, 2022 & 2030

Figure 5:  U.S. Plasma Fractionation Market Share (%), By Company, 2022

Table 1:  U.S. Plasma Fractionation Market Revenue (USD billion) Forecast, by Product, 2019–2030

Table 2:  U.S. Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2019–2030

Table 3:  U.S. Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2019–2030

U.S. Plasma Fractionation Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports